Zobrazeno 1 - 10
of 4 282
pro vyhledávání: '"β2-glycoprotein I"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Rheumatology & Autoimmunity, Vol 3, Iss 3, Pp 131-139 (2023)
Abstract Antiphospholipid syndrome (APS) is typically characterized by increased levels of three classes of antiphospholipid antibodies, namely lupus anticoagulant, anti‐β2‐glycoprotein I (anti‐β2GPI), and anticardiolipin antibodies. β2‐Gl
Externí odkaz:
https://doaj.org/article/b2931fb11b894367a54bd6509ccc4024
Autor:
Dasgupta, Swapan Kumar1 (AUTHOR), Gollamudi, Jahnavi2 (AUTHOR), Rivera, Stefanie1 (AUTHOR), Poche, Ross A.3 (AUTHOR), Rumbaut, Rolando E.2 (AUTHOR), Thiagarajan, Perumal1,2 (AUTHOR) perumalt@bcm.edu
Publikováno v:
PLoS ONE. 1/25/2024, Vol. 19 Issue 1, p1-15. 15p.
Publikováno v:
In Journal of Thrombosis and Haemostasis December 2023 21(12):3511-3521
Publikováno v:
Rheumatology & Autoimmunity. Sep2023, Vol. 3 Issue 3, p131-139. 9p.
Autor:
Moghbel, Marc, Roth, Aline, Baptista, Daniela, Miteva, Kapka, Burger, Fabienne, Montecucco, Fabrizio, Vuilleumier, Nicolas, Mach, François, Brandt, Karim J. *
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2022 6(7)
Autor:
Swapan Kumar Dasgupta, Jahnavi Gollamudi, Stefanie Rivera, Ross A Poche, Rolando E Rumbaut, Perumal Thiagarajan
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0293304 (2024)
β2-glycoprotein I (β2-Gp1) is a cardiolipin-binding plasma glycoprotein. It is evolutionarily conserved from invertebrates, and cardiolipin-bound β2-Gp1 is a major target of antiphospholipid antibodies seen in autoimmune disorders. Cardiolipin is
Externí odkaz:
https://doaj.org/article/76abe9879be04a7fb9a3f0cf4e70dd7f
Autor:
Kim SJ; Department of Bioengineering and Therapeutic Sciences, University of California at San Francisco, United States of America; Departments of Physics and Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea., Schneidman-Duhovny D; Department of Bioengineering and Therapeutic Sciences, University of California at San Francisco, United States of America; School of Computer Science and Engineering, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel., de Groot PG; Department of Functional Coagulation, Synapse Research Institute, Maastricht, the Netherlands; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Urbanus RT; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Carter L; Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA, United States of America., de Laat-Kremers R; Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, the Netherlands., Weiss TM; Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA, United States of America., Chan MK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States of America., Sali A; Department of Bioengineering and Therapeutic Sciences, University of California at San Francisco, United States of America., Rand JH; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, United States of America., de Laat B; Department of Functional Coagulation, Synapse Research Institute, Maastricht, the Netherlands; Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, the Netherlands. Electronic address: b.delaat@thrombin.com.
Publikováno v:
Thrombosis research [Thromb Res] 2024 May; Vol. 237, pp. 145-147. Date of Electronic Publication: 2024 Mar 28.
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 124-135 (2021)
Antibodies specific for cardiolipin (CL)-β2-glycoprotein I (β2GPI) are known to induce tissue factor (TF) expression by monocytes and endothelial cells which leads to a prothrombotic state in antiphospholipid syndrome (APS), but the mechanism is no
Externí odkaz:
https://doaj.org/article/01df479967374dbda7921f75dac4a14a
Autor:
Kumar, Suresh, Chinnaraj, Mathivanan, Planer, William, Zuo, Xiaobing, Macor, Paolo, Tedesco, Francesco, Pozzi, Nicola
Publikováno v:
In Journal of Biological Chemistry August 2021 297(2)